Fast tracking rare disease research
Published on January 27, 2017"We have long worked for an open-science, scalable approach to accelerate solutions for orphan and rare diseases."
"We have long worked for an open-science, scalable approach to accelerate solutions for orphan and rare diseases."
“We have long worked for an open-science, scalable approach to build research tools and support the necessary talent to accelerate solutions to ameliorate suffering in the millions of individuals affected by rare diseases.” –Bob Blouin, Dean, UNC Eshelman School of Pharmacy
Science has cracked the human genome, a monumental breakthrough in human existence to be sure. But translating that knowledge into new medicines has been extremely slow. This is especially true for rare diseases, which lack visibility, resources and research expertise.
UNC Catalyst, a new endeavor at the UNC Eshelman School of Pharmacy, will create and freely share the tools and knowledge missing in the study of many rare conditions.
For the people who suffer from one of the nearly 7,000 rare and orphaned diseases recognized by the National Institutes of Health, UNC Catalyst could mean the first step in new treatments that could make for a better life.
Read the complete Carolina Story…Opens in new window
UNC Catalyst was launched with a $2 million grant from the UNC Eshelman School of Pharmacy’s Eshelman Institute for Innovation.
